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Growth factorsAbstract For stem cell therapy of degenerative diseases, it is necessary to differentiate stem cells
into the speciﬁc lineage. There are several growth factors which have been used for differentiation
of stem cells. Some growth factors can dose-dependently induce differentiation of stem cells so that
the increase of growth factor concentration results in production of the higher level of differentiated
cells. However, due to the toxicity of some differentiation factors (e.g. retinoic acid), the lower dose
of growth factors for the speciﬁc lineage differentiation of stem cells is desirable. This paper suggests
a new approach in the ﬁeld of controlled growth factor delivery system using semiconductor
nanocrystals; known as quantum dots (QDs). This system contains polymeric microencapsulated
growth factor which is conjugated to near infrared (NIR) absorbing QDs. The control release of
growth factors from microcapsules in the culture plates can be achieved by irradiation. To modulate
growth factor release in response to stem cells needs for differentiation, the intensity and period of
irradiation will be controlled. Our hypothesis is based on the fact that QDs can absorb NIR energy
and by excitation of electrons and then vibrational relaxation of them become heated when they
were irradiated and then release growth factors. We believe that controlled growth factors delivery
through the suggested system is an effective method to reduce the amount of growth factors
required for differentiation of stem cells.
ª 2015 Tehran University of Medical Sciences. Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).711151,
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Stem cell therapy is a new approach to repair diseased tissues
or organs [1]. However, to achieve therapeutic efﬁcacy, differ-
entiation of stem cells into the speciﬁc lineage prior to trans-
plantation is often essential [2]. To differentiate stem cells
in vitro, growth factors are used [2,3]. The current common
method for differentiation of stem cells has been based on con-
tinuum concepts where the culture medium is supposed to be
homogeneous and an enough amount of growth factors is
assumed to be contained in the medium [4]. However, because
of Brownian motion of growth factor in the medium, only a
small amount reaches the cell receptors related to biological
signal pathways [4]. Therefore, even if a huge amount of
growth factor is added to culture medium to induce differen-
tiation, only a small fraction would be involved in differen-
tiation of stem cells. Therefore, the chance of growth factor
binding to cultured stem cells should be maximized to enhance
differentiation.
Moreover, the use of some of these growth factors presents
a signiﬁcant challenge due of their poor water solubility, short
half-life and potentially toxic effects. One example is all-trans-
retinoic acid (RA), a hydrophobic drug, which plays a funda-
mental role in the development of the central nervous system,
stimulating outgrowth and migration of the neural crest [5].
RA is one of the most important signaling molecules that pro-
mote neuralization in embryos [6–8]. RA, which can bind to
both RAR subtypes, is commonly employed to induce neu-
ronal differentiation in vitro. RA induces a pan-neuronal dif-
ferentiation and the cell population obtained after
application of this differentiation factor is relatively heteroge-
neous [9,10]. RA applied to embryonic stem cells (ESCs) can
induce concentration-dependent differentiation of neural cells.
Okada et al. [11] tested the effects of different concentrations
of RA on the neural differentiation of mouse (ESCs). Lower
RA levels were found to induce neural progenitor cells from
ESCs, indicated by the high protein expression of the neural
precursor marker nestin and low expression of mature neu-
ronal and glial markers beta-tubulin III and GFAP, respective-
ly. In contrast, high levels of RA (2 · 106 M) decreased the
expression of nestin while increasing beta-tubulin III and
GFAP levels. These results are consistent with other studies
demonstrating differentiation of neural progenitors at high
RA concentrations [12,13]. However, RA is a strong teratogen
and should be used at lower doses to prevent toxicity [7].
Therefore, a method that can reduce the amount of growth
factors required for cell differentiation should be developed.
In addition, RA is rapidly metabolized to inactive polar
metabolites such as all-trans-hydroxyl RA and all-trans-4-
oxo-RA. This rapid metabolism of RA is due to the induction
of the cytochrome P450 by RA [14]. To overcome such prob-
lem and to increase the differentiation efﬁciency of growth fac-
tors, a new approach is growth factor delivery from the cell
culture scaffolds. It has been shown that growth factor
released from a cell culture scaffold could bind to receptors
on the cultured stem cells much more efﬁciently than growth
factors added to the culture medium. Growth factor delivery
using a cell culture matrix could also potentially reduce the
amount of growth factor required for stem cell differentiation
[15,16]. Through this approach, it will be possible to have ade-
quate optimized differentiated cells for stem cell therapy andregenerative medicine and overcome the problem of donor cell
and tissue shortage.
Hypothesis
Conjugation of a growth factor such as RA to a synthetic cell
culture scaffold offers a localized release system for growth
factor. Immobilization of RA to the scaffolds results in very
slow release. In this study, we hypothesize a system of microen-
capsulated growth factor conjugated to near infrared (NIR)
absorbing quantum dot (QD), in which controlled release of
growth factors from the polymeric microcapsules is triggered
by NIR irradiation. The energy of NIR radiation is in the
vibrational levels of atoms and when a QD absorbs NIR, the
valence electron excited to the upper vibrational levels. Then
during 1010 to 1013 second electrons come back to prior
vibrational level and release excess energy in the heat form.
Our hypothesis is based on the fact that QDs can absorb
NIR energy and by excitation of electrons and then vibrational
relaxation of them become heated when they were irradiated
and then release growth factors. This system can externally
modulate release of growth factors like RA and EGF in
response to stem cells needs for differentiation by control of
the intensity and period of irradiation. We think by using this
system and controlling of time and amount of release, the low-
er levels of growth factors will be required (at physiological
level) to induce lineage-speciﬁc differentiation of stem cells.
The selectivity of release is depending on the type of differen-
tiation factor, intensity and period of NIR irradiation and the
other components of scaffold.
Evaluation of the hypothesis
To test this hypothesis, NIR-QDs (Cadmium-Selenide); semi-
conductor nanocrystals with size-dependent absorption and
emission, will be used. The surface chemistry of QD can regu-
late the solubility of QD, for example by addition of a layer of
amphiphilic molecules as well as can functionalize QD [3].
Since RA is a hydrophobic growth factor, at ﬁrst step it will
be required to carboxylate QD. Then, crosslinking agents
such as 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC) and sulfonated N-hydroxysuccinimide
(sulfo-NHS) will be used. In order to conjugate QDs and
RA, phenylene diamine (PDA) will be added to the activated
QDs and RA solutions (Fig. 1).
Microencapsulation of QD-RA will be performed by dou-
ble emulsion in solution of PCL and PLGA. After washing
with deionized water, the microcapsules will be lyophilized.
The morphology of microspheres will be examined with scan-
ning electron microscopy. To avoid enzymatic degradation of
the scaffold with matrix metalloproteinases secreted by stem
cells, it is necessary to use the synthetic scaffold. The cell cul-
ture plates will be coated with PLGA containing QD-RA
microspheres. The kinetics of growth factors release following
irradiation will be determined with HPLC. ESCs will be cul-
tured on PLGA scaffold loaded with the deﬁnite amount of
QD-RA microspheres. As a control, stem cells will be cultured
with daily addition of the same amounts of RA to the culture
medium. Neuronal differentiation will be determined using
neurite counting and Western blot analysis of neuronal mark-
ers expression. To optimize growth factors concentration in
Fig. 1 Diagram showing conjugation of retinoic acid on quantum dots.
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NIR irradiation will be evaluated as two independent vari-
ables. The amount of heat will be controlled by two mentioned
variables and temperature of incubator, so it would not be
toxic for the cells and affect the structure of drugs.
Discussion
For the past decades, technologies have been developed to
externally trigger the drug release according to physiological
needs. Magnetic, ultrasonic, thermal, and electric sources were
used for controlled drug delivery [17]. Semiconductor
nanocrystals (QDs), as another system for drug delivery, have
become an essential tool in biomedical research, especially for
multiplexed, quantitative and long-term ﬂuorescence imaging
and detection [18]. One of the most important emerging appli-
cations of QDs appears to be drug delivery. The basic rationale
for using QDs arises from their property which can absorb
NIR energy and emit their energy to release drugs [18]. The
absorbed light makes an electronic excitation possible in the
material, leaving the electron free in the conduction band. This
free electron can be put back into the valence band and create
heat.
We have chosen near IR irradiation because of its unique
properties. While NIR can penetrate several centimeters deep
into the cells and scaffolds, it is biocompatible and has no toxic
effect on the cells, hence NIR-active QDs can be used in a non-
invasive manner [19]. The emission spectral range of 700–
900 nm will be used in this study. The tunable release behavior
will be achieved by optimizing the intensity and period of NIR
exposition.
We explained RA in this study as one of the most studied
growth factors in the current stem cell differentiation proto-
cols. In previous studies, high dose of RA (50 lM) has been
used to investigate neural differentiation of stem cells [20–
22]. Although higher doses of RA can produce a high percent-
age of neural cells, RA is a strong teratogen and should
therefore be used at lower doses to prevent toxicity [7]. Werecently used a lower dose (1 lM) of RA to induce neural
marker expression in stem cells [2]. However, it should be
mentioned that also 1 lM of RA is a supraphysiological dose
and its toxic effects remain to be studied. We believe that the
current developed system based on NIR-active QD will help
us to decrease the concentration of growth factors to physio-
logical levels (e.g. the range of 10–100 nM for RA) to achieve
the desired speciﬁc lineage differentiation of stem cells.
One of the important aspects which should be considered in
this hypothesis is cytotoxicity of near-IR irradiation and
quantum dots. There are many reports on biocompatibility
of near-IR irradiation. As described, due to convenient and
precise manipulation, deep penetration through tissues and
excellent biocompatibility, near-IR irradiation is a preferred
external stimulus for triggering the release of loaded drugs [23].
In QDs, cytotoxicity is a consequence of the release of free
elements ions such as metal ions of Cadmium (Cd), selenium
(Se) and tellurium (Te) (CdSe and CdTe) in the cell culture
medium. Cadmium (Cd), selenium (Se) and tellurium (Te)
can be toxic elements for humans, causing toxicity in the kid-
neys, lungs, nervous system, in addition to DNA damage [24].
Therefore, any interaction of QD with an external factor which
results in the segregation of these atoms can initiate the release
of Cd and Se. A mechanism which decreases the QDs toxicity
is surface modiﬁcation of QDs such as the synthesis of a
passive layer to protect the nanoparticles from interaction with
the exogenous factors. Moreover, cytotoxicity of QDs is
dependent both on the irradiation power density and the QD
local concentration. It has been demonstrated that cells
containing QDs can maintain their biological functions in
good condition, remaining viable for several generations [25].
Conclusion
This hypothesis introduces a new approach in the ﬁeld of con-
trolled growth factor delivery systems using a novel quantum
dots. In this system, microencapsulated RA which is conjugat-
ed to NIR absorbing QDs will be added to cell culture matrix
Quantum dot-based drug delivery 27and the feasibility of controlled release of growth factor from
microcapsules by external irradiation will be evaluated. This
system may be used for controlled release of not only RA
for stem cell differentiation but also for the other lipophilic
drugs for various clinical applications.Overview box
First Question: What do we already know about the
subject?
A wide variety of techniques have been developed to
externally trigger the growth factor release according to
physiological needs. Magnetic, ultrasonic, thermal, and
electric sources were used for controlled drug delivery.
Based on the pivotal role and dose-dependent effects of
growth factor for differentiation of stem cells, it is neces-
sary to develop a new growth factor delivery system.
Second Question: What does your proposed theory add
to the current knowledge available, and what beneﬁts does
it have?
We propose here a new approach in the ﬁeld of con-
trolled growth factor delivery systems which contains
polymeric microencapsulated RA conjugated to near
infrared absorbing quantum dots. The control release of
RA from microcapsules in the culture plates can be
achieved by irradiation. We believe that this system will
help us to decrease the concentration of growth factor
for lineage-speciﬁc differentiation of stem cells.
Third question: Among numerous available studies, what
special further study is proposed for testing the idea?
At ﬁrst step it will be required to carboxylate QD.
Growth factor and QD will be conjugated. Microencapsu-
lation of QD-growth factor will be performed by double
emulsion. The kinetics of growth factor release will be
evaluated following irradiation before and after stem cell
cultures. Neuronal differentiation will be determined
using neurite counting and Western blot analysis of neu-
ronal markers expression.Conﬂict of interest
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